Demonstrates improved tumor imaging using low molecular weight QuCy dyes in vivo, suggesting their future clinical use.
Fluorescence-guided surgery (FGS) is limited by the shallow penetration and high autofluorescence of currently available NIR-I fluorophores. To address these constraints, we developed a class of low molecular weight organic fluorophores, 4,4'-quinocyanines (QuCy), that extend emission into the NIR-II (950-1700 nm) region. Rational design through substitution of indolenine head groups with N-substituted quinolinium moieties enhanced π-conjugation, reduced HOMO-LUMO gaps, and induced bathochromic shifts of up to 225 nm, confirmed by density functional theory and spectroscopic analyses. Five derivatives (JAM317-319, JAP331, JAP334) were synthesized via a modular route and exhibited emission maxima of 976-1004 nm. Compared with NIR-I dyes, QuCy dyes demonstrated improved depth penetration and contrast due to reduced tissue autofluorescence. In vivo evaluation of JAM317 revealed efficient tumor cell uptake, low cytotoxicity, and high-resolution vascular imaging. These findings establish QuCy dyes as a promising platform for clinically translatable NIR-II contrast agents.
No takes yet. Share an insight, caveat, or question.
Isuri et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: